once-weekly semaglutide in adults with overweight or obesity For patients with #obesity, semaglutide,

Nurx does not provide talk therapy or crisis management

Clinical trials conducted in overweight and obese patients (with or without diabetes) have shown that combining semaglutide with intensive behavioral therapy and a low-calorie diet resulted in up to 16.0% reduction in body weight

J Lab Med

2 Our prior research revealed a substantial increase in the number of patients prescribed drugs like Ozempic and Mounjaro

Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide

Retatrutide causes significant fat loss but also some lean mass loss if protein intake and training are not managed